Interferon-α 2b quantification in inclusion bodies using Reversed Phase-Ultra Performance Liquid Chromatography (RP-UPLC)

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 13-14, 2010, Pages 1019-1023

  Cueto Rojas, H F ^a   Perez N O ^a   Perez Sanchez G ^a   Ocampo Juarez I ^a   Medina Rivero, E ^a  

^a Probiomed SA de CV   (Mexico)

Author keywords

Inclusion body; Interferon 2b; UPLC; Validation

Indexed keywords

COLUMN TEMPERATURE; CYTOKINES; DETECTION AND QUANTIFICATION LIMIT; DETERMINATION COEFFICIENTS; E. COLI; EXPRESSION SYSTEM; HOST PROTEINS; INCLUSION BODIES; PREPARATION METHOD; PROTEIN PURIFICATION; RECOMBINANT PROTEIN; RELATIVE STANDARD DEVIATIONS; REVERSED PHASE; RUNTIMES; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANTIBIOTICS; ESCHERICHIA COLI; GLYCOPROTEINS; LIQUIDS; PROTEINS;

LIQUID CHROMATOGRAPHY;

ALPHA2B INTERFERON;

ARTICLE; CELL INCLUSION; ESCHERICHIA COLI; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLUBILIZATION; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; INCLUSION BODIES; INTERFERON ALFA-2B; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS;

ESCHERICHIA COLI;

EID: 77950242026     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.02.016     Document Type: Article

References (20)

1. Épshtein N.A. Pharm. Chem. J. 38 4 (2004) 212
2. Center of Drug Evaluation and Research: Reviewer Guidance, Validation of Chromatographic Methods, 1994.
3. Valente C.A., Monteiro G.A., Cabral J.M.S., et al. Protein Expr. Purif. 45 (2004) 226
4. Rao Dasari V.K., Are D., Rao Joginapally V., et al. Process Biochem. 43 (2008) 566
5. Magalhaes da Silva L., Bizogne Souto R., da Silva Sangoi M., and Dourado M. J. Liq. Chromatogr. Related Technol. 32 (2009) 370
6. Srivastava P., Bhattacharaya P., Pandey G., and Mukherjee K.J. Protein Expr. Purif. 41 (2005) 313
7. Zarrin A., Foroozesh M., Hamidi M., and Mohammadi-Samani S. J. Chromatogr. B 833 (2006) 199
8. Swartz M.E. J. Liq. Chromatogr. Related Technol. 28 (2005) 1253
9. Friedman R.M. Br. J. Clin. Pharmacol. 65 4 (2004) 212
10. Matthwes S.J., and McCoy C. Clin. Ther. 26 7 (2004) 991
11. Von Gabain A., Lundgren E., Ohlsson M., et al. Eur. J. Biochem. 190 (1990) 257
12. Billiau A. Cytokine Growth Factor Rev. 17 (2006) 381
13. Youngster S., Wang Y.S., Grace M., et al. Curr. Pharm. Des. 8 (2002) 2139
14. Goedel D.V., Yelverton E., Ullrich A., et al. Nature 287 5781 (1980) 411
15. Babu K.R., Swaminathan S., Marten S., et al. Appl. Microbiol. Biotechnol. 53 (2000) 655
16. Bromage E.S., and Kaattari S.L. J. Immunol. Methods 323 (2007) 109
17. British Pharmacopeia, vol. I, The Stationery Office, London, UK, 1998, p. 728.
18. Samuel C.E. Clin. Microbiol. Rev. 14 4 (2001) 778
19. Wang J., Li H., Jin C., et al. J. Pharm. Biomed. Anal. 47 (2008) 765
20. International Conference on Harmonisation (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validations of Analytical Procedures: Text and Methodology Q2 (R1), November 2005, pp. 1-13.